Visual loss following high-dose cytosine arabinoside (ARA-C) [4]

European Journal of Haematology

Volumn 64, Issue 3, 2000, Pages 208-209

  Schwartz, Joseph ^a,b   Alster, Yair ^a   Ben Tal, Ofira ^a   Lowenstein, Anat ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CYTARABINE; ETOPOSIDE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; LETTER; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ADULT; CYTARABINE; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NERVOUS SYSTEM DISEASES; VISION DISORDERS;

EID: 0034061511     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.9l101.x     Document Type: Letter

References (5)